China SXT Pharmaceuticals, Inc.
SXTC
$4.15
$0.8525.87%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 106.55% | 106.55% | -693.52% | -693.52% | -137.91% |
| Total Depreciation and Amortization | 33.65% | 33.65% | -53.06% | -53.06% | -65.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 440.50% |
| Total Other Non-Cash Items | -193.39% | -193.39% | 15,924.71% | 15,924.71% | 116.16% |
| Change in Net Operating Assets | -520.05% | -520.05% | -32.98% | -32.98% | 67.68% |
| Cash from Operations | -129.18% | -129.18% | -29.13% | -29.13% | 26.71% |
| Capital Expenditure | -- | -- | -- | -- | 71.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,519.13% | -1,519.13% | -2,377.34% | -2,377.34% | 238.24% |
| Total Debt Issued | -30.96% | -30.96% | -95.84% | -95.84% | -77.46% |
| Total Debt Repaid | 85.80% | 85.80% | -47.57% | -47.57% | -419.85% |
| Issuance of Common Stock | 230.07% | 230.07% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 38.77% |
| Cash from Financing | 679.90% | 679.90% | -25.79% | -25.79% | -36.76% |
| Foreign Exchange rate Adjustments | 187.49% | 187.49% | -27.34% | -27.34% | -597.60% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,920.24% | 1,920.24% | -52.33% | -52.33% | -162.63% |